Increased Impact of Serum Uric Acid on Arterial Stiffness and Atherosclerosis in Females
Aims: Serum uric acid increases with metabolic disorders; however, whether the effects of uric acid on atherosclerosis are different in females and males has not been sufficiently evaluated. Therefore, this study compared the impact of uric acid on arterial stiffness and atherosclerosis between fema...
Saved in:
| Published in | Journal of Atherosclerosis and Thrombosis Vol. 29; no. 11; pp. 1672 - 1691 |
|---|---|
| Main Authors | , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Japan
Japan Atherosclerosis Society
01.11.2022
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Aims: Serum uric acid increases with metabolic disorders; however, whether the effects of uric acid on atherosclerosis are different in females and males has not been sufficiently evaluated. Therefore, this study compared the impact of uric acid on arterial stiffness and atherosclerosis between females and males.Methods: We enrolled 10196 untreated middle-aged subjects (46±8 years, 3021 females and 7175 males) who underwent periodic health check-ups. Serum uric acid levels were measured and arterial stiffness and atherosclerosis were assessed by the cardio-ankle vascular index (CAVI), carotid intima-media thickness (IMT), and plaque, using ultrasound imaging.Results: Females with increased arterial stiffness (CAVI ≥ 8.0) or carotid plaques had higher uric acid than those without (P＜0.0001), but males did not. In multivariable regression analyses including overall participants, uric acid was significantly associated with the CAVI, where sex interacted with uric acid. In sex-specific analyses, uric acid was significantly associated with the CAVI, but not with carotid IMT, in both sexes. However, logistic regression analyses revealed that serum uric acid was independently associated with the presence of carotid plaques in females. The exclusion of subjects with abdominal obesity or metabolic syndrome from the analysis did not alter the results in females.Conclusions: Serum uric acid was significantly associated with the CAVI in both sexes, but the interaction of sex was confirmed and associated with a carotid plaque only in females. These findings support the increased impact of serum uric acid on arterial stiffness and atherosclerosis in females. |
|---|---|
| AbstractList | AIMSSerum uric acid increases with metabolic disorders; however, whether the effects of uric acid on atherosclerosis are different in females and males has not been sufficiently evaluated. Therefore, this study compared the impact of uric acid on arterial stiffness and atherosclerosis between females and males. METHODSWe enrolled 10196 untreated middle-aged subjects (46±8 years, 3021 females and 7175 males) who underwent periodic health check-ups. Serum uric acid levels were measured and arterial stiffness and atherosclerosis were assessed by the cardio-ankle vascular index (CAVI), carotid intima-media thickness (IMT), and plaque, using ultrasound imaging. RESULTSFemales with increased arterial stiffness (CAVI ≥ 8.0) or carotid plaques had higher uric acid than those without (P＜0.0001), but males did not. In multivariable regression analyses including overall participants, uric acid was significantly associated with the CAVI, where sex interacted with uric acid. In sex-specific analyses, uric acid was significantly associated with the CAVI, but not with carotid IMT, in both sexes. However, logistic regression analyses revealed that serum uric acid was independently associated with the presence of carotid plaques in females. The exclusion of subjects with abdominal obesity or metabolic syndrome from the analysis did not alter the results in females. CONCLUSIONSSerum uric acid was significantly associated with the CAVI in both sexes, but the interaction of sex was confirmed and associated with a carotid plaque only in females. These findings support the increased impact of serum uric acid on arterial stiffness and atherosclerosis in females. [Aims]: Serum uric acid increases with metabolic disorders; however, whether the effects of uric acid on atherosclerosis are different in females and males has not been sufficiently evaluated. Therefore, this study compared the impact of uric acid on arterial stiffness and atherosclerosis between females and males. [Methods]: We enrolled 10196 untreated middle-aged subjects (46+-8 years, 3021 females and 7175 males) who underwent periodic health check-ups. Serum uric acid levels were measured and arterial stiffness and atherosclerosis were assessed by the cardio-ankle vascular index (CAVI), carotid intima-media thickness (IMT), and plaque, using ultrasound imaging. [Results]: Females with increased arterial stiffness (CAVI >- 8.0) or carotid plaques had higher uric acid than those without (P<0.0001), but males did not. In multivariable regression analyses including overall participants, uric acid was significantly associated with the CAVI, where sex interacted with uric acid. In sex-specific analyses, uric acid was significantly associated with the CAVI, but not with carotid IMT, in both sexes. However, logistic regression analyses revealed that serum uric acid was independently associated with the presence of carotid plaques in females. The exclusion of subjects with abdominal obesity or metabolic syndrome from the analysis did not alter the results in females. [Conclusions]: Serum uric acid was significantly associated with the CAVI in both sexes, but the interaction of sex was confirmed and associated with a carotid plaque only in females. These findings support the increased impact of serum uric acid on arterial stiffness and atherosclerosis in females. Aims: Serum uric acid increases with metabolic disorders; however, whether the effects of uric acid on atherosclerosis are different in females and males has not been sufficiently evaluated. Therefore, this study compared the impact of uric acid on arterial stiffness and atherosclerosis between females and males. Methods: We enrolled 10196 untreated middle-aged subjects (46±8 years, 3021 females and 7175 males) who underwent periodic health check-ups. Serum uric acid levels were measured and arterial stiffness and atherosclerosis were assessed by the cardio-ankle vascular index (CAVI), carotid intima-media thickness (IMT), and plaque, using ultrasound imaging. Results: Females with increased arterial stiffness (CAVI ≥ 8.0) or carotid plaques had higher uric acid than those without ( P ＜0.0001), but males did not. In multivariable regression analyses including overall participants, uric acid was significantly associated with the CAVI, where sex interacted with uric acid. In sex-specific analyses, uric acid was significantly associated with the CAVI, but not with carotid IMT, in both sexes. However, logistic regression analyses revealed that serum uric acid was independently associated with the presence of carotid plaques in females. The exclusion of subjects with abdominal obesity or metabolic syndrome from the analysis did not alter the results in females. Conclusions: Serum uric acid was significantly associated with the CAVI in both sexes, but the interaction of sex was confirmed and associated with a carotid plaque only in females. These findings support the increased impact of serum uric acid on arterial stiffness and atherosclerosis in females. Aims: Serum uric acid increases with metabolic disorders; however, whether the effects of uric acid on atherosclerosis are different in females and males has not been sufficiently evaluated. Therefore, this study compared the impact of uric acid on arterial stiffness and atherosclerosis between females and males.Methods: We enrolled 10196 untreated middle-aged subjects (46±8 years, 3021 females and 7175 males) who underwent periodic health check-ups. Serum uric acid levels were measured and arterial stiffness and atherosclerosis were assessed by the cardio-ankle vascular index (CAVI), carotid intima-media thickness (IMT), and plaque, using ultrasound imaging.Results: Females with increased arterial stiffness (CAVI ≥ 8.0) or carotid plaques had higher uric acid than those without (P＜0.0001), but males did not. In multivariable regression analyses including overall participants, uric acid was significantly associated with the CAVI, where sex interacted with uric acid. In sex-specific analyses, uric acid was significantly associated with the CAVI, but not with carotid IMT, in both sexes. However, logistic regression analyses revealed that serum uric acid was independently associated with the presence of carotid plaques in females. The exclusion of subjects with abdominal obesity or metabolic syndrome from the analysis did not alter the results in females.Conclusions: Serum uric acid was significantly associated with the CAVI in both sexes, but the interaction of sex was confirmed and associated with a carotid plaque only in females. These findings support the increased impact of serum uric acid on arterial stiffness and atherosclerosis in females. Serum uric acid increases with metabolic disorders; however, whether the effects of uric acid on atherosclerosis are different in females and males has not been sufficiently evaluated. Therefore, this study compared the impact of uric acid on arterial stiffness and atherosclerosis between females and males. We enrolled 10196 untreated middle-aged subjects (46±8 years, 3021 females and 7175 males) who underwent periodic health check-ups. Serum uric acid levels were measured and arterial stiffness and atherosclerosis were assessed by the cardio-ankle vascular index (CAVI), carotid intima-media thickness (IMT), and plaque, using ultrasound imaging. Females with increased arterial stiffness (CAVI ≥ 8.0) or carotid plaques had higher uric acid than those without (P＜0.0001), but males did not. In multivariable regression analyses including overall participants, uric acid was significantly associated with the CAVI, where sex interacted with uric acid. In sex-specific analyses, uric acid was significantly associated with the CAVI, but not with carotid IMT, in both sexes. However, logistic regression analyses revealed that serum uric acid was independently associated with the presence of carotid plaques in females. The exclusion of subjects with abdominal obesity or metabolic syndrome from the analysis did not alter the results in females. Serum uric acid was significantly associated with the CAVI in both sexes, but the interaction of sex was confirmed and associated with a carotid plaque only in females. These findings support the increased impact of serum uric acid on arterial stiffness and atherosclerosis in females. |
| ArticleNumber | 63368 |
| Author | Yokochi, Takashi Nagami, Takashi Tomiishi, Takamasa Dohi, Yasuaki Takagi, Yasuyuki Suzuki, Kenji Ohte, Nobuyuki Yoshikane, Naofumi Seo, Yoshihiro Iwase, Mitsunori Sugiura, Tomonori Takase, Hiroyuki |
| Author_xml | – sequence: 1 fullname: Sugiura, Tomonori organization: Department of Cardiology, Nagoya City University Graduate School of Medical Sciences – sequence: 2 fullname: Dohi, Yasuaki organization: Health Support Center WELPO, Toyota Motor Corporation – sequence: 3 fullname: Takagi, Yasuyuki organization: Health Support Center WELPO, Toyota Motor Corporation – sequence: 4 fullname: Yokochi, Takashi organization: Health Support Center WELPO, Toyota Motor Corporation – sequence: 5 fullname: Yoshikane, Naofumi organization: Health Support Center WELPO, Toyota Motor Corporation – sequence: 6 fullname: Suzuki, Kenji organization: Health Support Center WELPO, Toyota Motor Corporation – sequence: 7 fullname: Tomiishi, Takamasa organization: Health Support Center WELPO, Toyota Motor Corporation – sequence: 8 fullname: Nagami, Takashi organization: Health Support Center WELPO, Toyota Motor Corporation – sequence: 9 fullname: Iwase, Mitsunori organization: Toyota Memorial Hospital – sequence: 10 fullname: Takase, Hiroyuki organization: Department of Cardiology, Nagoya City University Graduate School of Medical Sciences – sequence: 11 fullname: Ohte, Nobuyuki organization: Department of Cardiology, Nagoya City University Graduate School of Medical Sciences – sequence: 12 fullname: Seo, Yoshihiro organization: Department of Cardiology, Nagoya City University Graduate School of Medical Sciences |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35110425$$D View this record in MEDLINE/PubMed |
| BookMark | eNpVUU1vEzEQtVAR_YADfwD5CIcUf9t7QUQVLZEqcSiVuFle72zjaNcOtoPov8dNSgSX55Hm-c3Me-foJKYICL2l5FJKST9uXL1UnCvzAp1RY8iCG81PWs1Fq4U2p-i8lA0hnEvJXqFTLiklgskz9GMVfQZXYMCreet8xWnEd5B3M77PweOlDwNOES9zhRzchO9qGMcIpWAXB7ysa8ip-OkJQ8Eh4muY3QTlNXo5uqnAm-f3At1ff_l-9XVx--1mdbW8XXgleF1wCR1VBDjV4Hvfa-2UYNrzwRCjgIJ2hPle9v1guPaM6VGYTggDdATNDL9Anw66210_w-Ah1uwmu81hdvnRJhfs_50Y1vYh_bKdYpzorgm8fxbI6ecOSrVzKB6myUVIu2KZYpIpIoVo1A8Hqm_XlgzjcQwl9ikJ25Kw-yQa992_ex2Zf61vhJsDoXWDd1OKU4hgN2mXYzPMwm89pPnRWUYYs4SwjlJLKLdUadago4KYrnnRlD4flDalugc4jnK5hpbMfinW2fa94X67Y8uvXbYQ-R_0orPY |
| CitedBy_id | crossref_primary_10_1007_s13167_022_00298_x crossref_primary_10_3390_biomedicines11071897 crossref_primary_10_5551_jat_63907 crossref_primary_10_1111_1756_185X_15043 crossref_primary_10_1038_s41440_024_01591_0 |
| Cites_doi | 10.1152/physrev.00033.2011 10.1186/s40885-020-00146-y 10.5551/jat.13.101 10.1161/HYPERTENSIONAHA.116.08114 10.1161/01.ATV.0000161274.87407.26 10.1016/j.jjcc.2012.07.005 10.1093/ajcn/87.5.1480 10.1007/s13340-018-0385-8 10.1177/1559827615601973 10.1007/s10396-009-0238-y 10.1253/circj.70.960 10.5551/jat.55996 10.1016/j.jare.2016.11.004 10.1172/JCI42344 10.3899/jrheum.080646 10.1016/0378-5122(90)90059-F 10.1016/j.cca.2008.02.024 10.1038/s41440-019-0284-9 10.2147/TCRM.S232033 10.1097/MD.0000000000007710 10.5551/jat.39685 10.5551/jat.GL2017 10.1186/s12944-018-0712-x 10.1038/hr.2012.192 10.2174/138161205774913255 10.1016/j.jacc.2011.08.080 10.1253/circj.72.598 10.1016/j.atherosclerosis.2015.01.011 10.1016/j.amjmed.2011.09.033 10.1016/j.cca.2018.05.046 10.1159/000355405 10.1016/S0140-6736(11)61055-6 10.1016/j.echo.2007.11.011 10.2174/138161205774913273 10.5551/jat.6866 10.1097/BOR.0b013e32835d951e 10.1016/j.atherosclerosis.2006.04.016 10.1080/15257770802138558 10.3390/nu12092509 10.5551/jat.31989 10.1016/j.ijcard.2015.08.109 10.1016/j.atherosclerosis.2013.08.017 10.5551/jat.50633 10.2147/VHRM.S23097 10.1371/journal.pone.0180406 10.1146/annurev-physiol-021113-170343 10.1016/0026-0495(86)90152-6 |
| ContentType | Journal Article |
| Copyright | This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License. 2022 Japan Atherosclerosis Society 2022 |
| Copyright_xml | – notice: This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License. – notice: 2022 Japan Atherosclerosis Society 2022 |
| CorporateAuthor | Nagoya City University Graduate School of Medical Sciences Toyota Memorial Hospital Department of Cardiology Department of Internal Medicine Midtown Clinic Meieki Enshu Hospital Toyota Motor Corporation Faculty of Rehabilitation Sciences Nagoya Gakuin University Health Support Center WELPO |
| CorporateAuthor_xml | – name: Midtown Clinic Meieki – name: Health Support Center WELPO – name: Enshu Hospital – name: Nagoya City University Graduate School of Medical Sciences – name: Toyota Memorial Hospital – name: Department of Cardiology – name: Nagoya Gakuin University – name: Department of Internal Medicine – name: Toyota Motor Corporation – name: Faculty of Rehabilitation Sciences |
| DBID | NPM AAYXX CITATION 7X8 5PM |
| DOI | 10.5551/jat.63368 |
| DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1880-3873 |
| EndPage | 1691 |
| ExternalDocumentID | 10_5551_jat_63368 35110425 ex7domya_2022_002911_013_1672_16914089894 article_jat_29_11_29_63368_article_char_en |
| Genre | Journal Article |
| GroupedDBID | --- .55 29J 2WC 53G 5GY 5VS ACGFO ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL DIK DU5 E3Z F5P GROUPED_DOAJ GX1 HYE JMI JSF JSH KQ8 M~E OK1 P6G RJT RNS RPM RZJ TR2 X7M 3O- TKC NPM AAYXX CITATION 7X8 5PM |
| ID | FETCH-LOGICAL-c643t-35e9160e317ecbcb77a6427c3d8086e1e7a02cb5bbd837c227f489448e1fe7283 |
| IEDL.DBID | RPM |
| ISSN | 1340-3478 |
| IngestDate | Fri Sep 01 02:39:27 EDT 2023 Fri Apr 12 09:36:00 EDT 2024 Fri Aug 23 02:17:03 EDT 2024 Thu May 23 23:37:28 EDT 2024 Fri Nov 08 06:54:44 EST 2024 Wed Apr 05 08:03:54 EDT 2023 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 11 |
| Keywords | Female Carotid plaque Uric acid Sex difference Atherosclerosis |
| Language | English |
| License | This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.http://creativecommons.org/licenses/by-nc-sa/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c643t-35e9160e317ecbcb77a6427c3d8086e1e7a02cb5bbd837c227f489448e1fe7283 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623079/ |
| PMID | 35110425 |
| PQID | 2625260544 |
| PQPubID | 23479 |
| PageCount | 20 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9623079 proquest_miscellaneous_2625260544 crossref_primary_10_5551_jat_63368 pubmed_primary_35110425 medicalonline_journals_ex7domya_2022_002911_013_1672_16914089894 jstage_primary_article_jat_29_11_29_63368_article_char_en |
| PublicationCentury | 2000 |
| PublicationDate | 20221101 |
| PublicationDateYYYYMMDD | 2022-11-01 |
| PublicationDate_xml | – month: 11 year: 2022 text: 20221101 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Japan |
| PublicationPlace_xml | – name: Japan |
| PublicationTitle | Journal of Atherosclerosis and Thrombosis |
| PublicationTitleAlternate | JAT |
| PublicationYear | 2022 |
| Publisher | Japan Atherosclerosis Society |
| Publisher_xml | – name: Japan Atherosclerosis Society |
| References | 10) Sharaf El Din UAA, Salem MM, Abdulazim DO. Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review. J Adv Res, 2017; 8: 537-548 23) Bae JS, Shin DH, Park PS, Choi BY, Kim MK, Shin MH, et al. The impact of serum uric acid level on arterial stiffness and carotid atherosclerosis: the Korean Multi-Rural Communities Cohort study. Atherosclerosis, 2013; 231: 145-151 33) Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, Horio T, Hoshide S, Ikeda S, Ishimitsu T, Ito M, Ito S, Iwashima Y, Kai H, Kamide K, Kanno Y, Kashihara N, Kawano Y, Kikuchi T, Kitamura K, Kitazono T, Kohara K, Kudo M, Kumagai H, Matsumura K, Matsuura H, Miura K, Mukoyama M, Nakamura S, Ohkubo T, Ohya Y, Okura T, Rakugi H, Saitoh S, Shibata H, Shimosawa T, Suzuki H, Takahashi S, Tamura K, Tomiyama H, Tsuchihashi T, Ueda S, Uehara Y, Urata H, Hirawa N. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res, 2019; 42: 1235-1481 37) Sugiura T, Dohi Y, Takagi Y, Yoshikane N, Ito M, Suzuki K, Nagami T, Iwase M, Seo Y, Ohte N. Relationships of Obesity-Related Indices and Metabolic Syndrome with Subclinical Atherosclerosis in Middle-Aged Untreated Japanese Workers. J Atheroscler Thromb, 2020; 27: 342-352 9) Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol, 2016; 213: 8-14 13) Grundy SM. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol, 2012; 59: 635-643 35) Haneda M, Noda M, Origasa H, Noto H, Yabe D, Fujita Y, Goto A, Kondo T, Araki E. Japanese Clinical Practice Guideline for Diabetes 2016. Diabetol Int, 2018; 9: 1-45 (Erratum in: Diabetol Int, 2018; 10: 83, Erratum in: Diabetol Int, 2019; 11: 163 14) Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Physiol Rev, 2013; 93: 359-404 40) Hu H, Cui H, Han W, Ye L, Qiu W, Yang H, Zhang C, Guo X, Mao G. A cutoff point for arterial stiffness using the cardio-ankle vascular index based on carotid arteriosclerosis. A cutoff point for arterial stiffness using the cardio-ankle vascular index based on carotid arteriosclerosis. Hypertens Res, 2013, 36: 334-341 24) Nagayama D, Yamaguchi T, Saiki A, Imamura H, Sato Y, Ban N, Kawana H, Nagumo A, Shirai K, Tatsuno I. High serum uric acid is associated with increased cardio-ankle vascular index (CAVI) in healthy Japanese subjects: a cross-sectional study. Atherosclerosis, 2015; 239: 163-168 15) Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Definition and the diagnostic standard for metabolic syndrome-Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Nihon Naika Gakkai Zasshi, 2005; 94: 794-809 12) Lee SJ, Oh BK, Sung KC. Uric acid and cardiometabolic diseases. Clin Hypertens, 2020; 26: 13 4) Mandal AK, Mount DB. The molecular physiology of uric acid homeostasis. Annu Rev Physiol, 2015; 77: 323-345 11) Ndrepepa G. Uric acid and cardiovascular disease. Clin Chim Acta, 2018; 484: 150-163 20) Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids, 2008; 27: 608-619 32) Neogi T, Ellison RC, Hunt S, Terkeltaub R, Felson DT, Zhang Y. Serum uric acid is associated with carotid plaques: the National Heart, Lung, and Blood Institute Family Heart Study. J Rheumatol, 2009; 36: 378-384 5) Schlesinger N. Dietary factors and hyperuricaemia. Curr Pharm Des, 2005; 11: 4133-4138 25) Liu H, Liu J, Zhao H, Zhou Y, Li L, Wang H; BEST Research Group. Relationship between Serum Uric Acid and Vascular Function and Structure Markers and Gender Difference in a Real-World Population of China-From Beijing Vascular Disease Patients Evaluation Study (BEST) Study. J Atheroscler Thromb, 2018; 25: 254-261 16) Ikeda N, Saito E, Kondo N, Inoue M, Ikeda S, Satoh T, Wada K, Stickley A, Katanoda K, Mizoue T, Noda M, Iso H, Fujino Y, Sobue T, Tsugane S, Naghavi M, Ezzati M, Shibuya K. What has made the population of Japan healthy? Lancet, 2011; 378: 1094-1105 1) So A, Thorens B. Uric acid transport and disease. J Clin Invest, 2010; 120: 1791-1799 7) Kakutani-Hatayama M, Kadoya M, Okazaki H, Kurajoh M, Shoji T, Koyama H, Tsutsumi Z, Moriwaki Y, Namba M, Yamamoto T. Nonpharmacological Management of Gout and Hyperuricemia: Hints for Better Lifestyle. Am J Lifestyle Med, 2015; 11: 321-329 21) Lippi G, Montagnana M, Franchini M, Favaloro EJ, Targher G. The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta, 2008; 392: 1-7 8) Chaudhary K, Malhotra K, Sowers J, Aroor A. Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med, 2013; 3: 208-220 38) Shirai K, Utino J, Otsuka K, Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb, 2006, 13: 101-107 29) Choi HY, Kim SH, Choi AR, Kim SG, Kim H, Lee JE, Kim HJ, Park HC. Hyperuricemia and risk of increased arterial stiffness in healthy women based on health screening in Korean population. PLoS One, 2017; 12: e0180406 39) Nakamura K, Tomaru T, Yamamura S, Miyashita Y, Shirai K, Noike H. Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ J, 2008, 72: 598-604 44) Nezu T, Hosomi N, Aoki S, Matsumoto M. Carotid Intima-Media Thickness for Atherosclerosis. J Atheroscler Thromb, 2016; 23: 18-31 47) Nezu T, Hosomi N, Aoki S, Matsumoto M. Carotid Intima-Media Thickness for Atherosclerosis. J Atheroscler Thromb, 2016; 23: 18-31 27) Albu A, Para I, Porojan M. Uric Acid and Arterial Stiffness. Ther Clin Risk Manag, 2020; 16: 39-54 43) Terminology and Diagnostic Criteria Committee, Japan Society of Ultrasonics in Medicine. Standard method for ultrasound evaluation of carotid artery lesions. J Med Ultrason (2001), 2009; 36: 219-226 49) Sugiura T, Dohi Y, Takagi Y, Yokochi T, Yoshikane N, Suzuki K, Tomiishi T, Nagami T, Iwase M, Takase H, Seo Y, Ohte N. Close Association between Subclinical Atherosclerosis and Pulmonary Function in Middle-Aged Male Smokers. J Atheroscler Thromb, 2020; 27: 1230-1242 42) Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, Najjar SS, Rembold CM, Post WS; American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr, 2008; 21: 93-111 34) Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, Umemoto S, Egusa G, Ohmura H, Okamura T, Kihara S, Koba S, Saito I, Shoji T, Daida H, Tsukamoto K, Deguchi J, Dohi S, Dobashi K, Hamaguchi H, Hara M, Hiro T, Biro S, Fujioka Y, Maruyama C, Miyamoto Y, Murakami Y, Yokode M, Yoshida H, Rakugi H, Wakatsuki A, Yamashita S; Committee for Epidemiology and Clinical Management of Atherosclerosis. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017. J Atheroscler Thromb, 2018; 25: 846-984 17) Nakamura Y, Yamamoto T, Okamura T, Kadowaki T, Hayakawa T, Kita Y, Saitoh S, Okayama A, Ueshima H; NIPPON DATA 80 Research Group. Combined cardiovascular risk factors and outcome: NIPPON DATA80, 1980-1994. Circ J, 2006; 70: 960-964 18) Iso H. Lifestyle and cardiovascular disease in Japan. J Atheroscler Thromb, 2011; 18: 83-88 26) Cassano V, Crescibene D, Hribal ML, Pelaia C, Armentaro G, Magurno M, Toscani A, Miceli S, Andreozzi F, Maio R, Perticone M, Sesti G, Perticone F, Sciacqua A. Uric Acid and Vascular Damage in Essential Hypertension: Role of Insulin Resistance. Nutrients, 2020; 12: 2509 28) Canepa M, Viazzi F, Strait JB, Ameri P, Pontremoli R, Brunelli C, Studenski S, Ferrucci L, Lakatta EG, AlGhatrif M. Longitudinal Association Between Serum Uric Acid and Arterial Stiffness: Results From the Baltimore Longitudinal Study of Aging. Hypertension, 2017; 69: 228-235 48) Takase H, Sugiura T, Murai S, Yamashita S, Ohte N, Dohi Y. Carotid intima-media thickness is a novel predictor of new onset of hypertension in normotensive subjects. Medicine (Baltimore), 2017; 96: e7710 46) Sugiura T, Dohi Y, Takase H, Yamashita S, Tanaka S, Kimura G. Increased reactive oxygen metabolites is associated with cardiovascular risk factors and vascular endothelial damage in middle-aged Japanese subjects. Vasc Health Risk Manag, 2011; 7: 475-482 3) Zhu Y, Pandya BJ, Choi HK. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. Am J Med, 2012; 125: 679-687 45) Antón FM, García Puig J, Ramos T, González P, Ordás J. Sex differences in uric acid metabolism in adults: evidence for a lack of influence of estradiol-17 beta (E2) on the renal handling of urate. Metabolism, 1986; 35: 343-348 31) Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol, 2005; 25: 1038-1044 41) Park HE, Choi SY, Kim MK, Oh BH. Cardio-ankle vascular index reflects coronary atherosclerosis in patients with abnormal glucose metabolism: assessment with 256 slice multi-detector computed tomography. J Cardiol, 2012; 60: 372-376 22) Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M. Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals. Atherosclerosis, 2007; 192: 131-137 2) Li C, Hsieh MC, Chang SJ. Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol, 2013; 25: 210-216 6) Williams PT. Effects of diet, physical activity and performance, and body weight on incident gout in ostensibly healthy, vigorously active men. Am J Clin Nutr, 2008; 87: 1480-1487 19) Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr Pharm Des, 2005; 11: 4145-4151 30) Zheng X, Wei Q, Long J, Gong L, Chen H, Lu 44 45 46 47 48 49 10 11 12 13 14 15 16 17 18 19 1 2 3 4 5 6 7 8 9 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 |
| References_xml | – ident: 14 doi: 10.1152/physrev.00033.2011 – ident: 12 doi: 10.1186/s40885-020-00146-y – ident: 38 doi: 10.5551/jat.13.101 – ident: 28 doi: 10.1161/HYPERTENSIONAHA.116.08114 – ident: 31 doi: 10.1161/01.ATV.0000161274.87407.26 – ident: 41 doi: 10.1016/j.jjcc.2012.07.005 – ident: 6 doi: 10.1093/ajcn/87.5.1480 – ident: 35 doi: 10.1007/s13340-018-0385-8 – ident: 7 doi: 10.1177/1559827615601973 – ident: 43 doi: 10.1007/s10396-009-0238-y – ident: 17 doi: 10.1253/circj.70.960 – ident: 49 doi: 10.5551/jat.55996 – ident: 10 doi: 10.1016/j.jare.2016.11.004 – ident: 1 doi: 10.1172/JCI42344 – ident: 32 doi: 10.3899/jrheum.080646 – ident: 36 doi: 10.1016/0378-5122(90)90059-F – ident: 21 doi: 10.1016/j.cca.2008.02.024 – ident: 33 doi: 10.1038/s41440-019-0284-9 – ident: 27 doi: 10.2147/TCRM.S232033 – ident: 48 doi: 10.1097/MD.0000000000007710 – ident: 25 doi: 10.5551/jat.39685 – ident: 34 doi: 10.5551/jat.GL2017 – ident: 30 doi: 10.1186/s12944-018-0712-x – ident: 40 doi: 10.1038/hr.2012.192 – ident: 19 doi: 10.2174/138161205774913255 – ident: 13 doi: 10.1016/j.jacc.2011.08.080 – ident: 39 doi: 10.1253/circj.72.598 – ident: 24 doi: 10.1016/j.atherosclerosis.2015.01.011 – ident: 3 doi: 10.1016/j.amjmed.2011.09.033 – ident: 11 doi: 10.1016/j.cca.2018.05.046 – ident: 8 doi: 10.1159/000355405 – ident: 16 doi: 10.1016/S0140-6736(11)61055-6 – ident: 42 doi: 10.1016/j.echo.2007.11.011 – ident: 5 doi: 10.2174/138161205774913273 – ident: 18 doi: 10.5551/jat.6866 – ident: 2 doi: 10.1097/BOR.0b013e32835d951e – ident: 22 doi: 10.1016/j.atherosclerosis.2006.04.016 – ident: 20 doi: 10.1080/15257770802138558 – ident: 26 doi: 10.3390/nu12092509 – ident: 44 doi: 10.5551/jat.31989 – ident: 9 doi: 10.1016/j.ijcard.2015.08.109 – ident: 15 – ident: 23 doi: 10.1016/j.atherosclerosis.2013.08.017 – ident: 37 doi: 10.5551/jat.50633 – ident: 46 doi: 10.2147/VHRM.S23097 – ident: 29 doi: 10.1371/journal.pone.0180406 – ident: 4 doi: 10.1146/annurev-physiol-021113-170343 – ident: 47 doi: 10.5551/jat.31989 – ident: 45 doi: 10.1016/0026-0495(86)90152-6 |
| SSID | ssj0033552 ssib002822083 |
| Score | 2.4116054 |
| Snippet | Aims: Serum uric acid increases with metabolic disorders; however, whether the effects of uric acid on atherosclerosis are different in females and males has... [Aims]: Serum uric acid increases with metabolic disorders; however, whether the effects of uric acid on atherosclerosis are different in females and males has... Serum uric acid increases with metabolic disorders; however, whether the effects of uric acid on atherosclerosis are different in females and males has not... AIMSSerum uric acid increases with metabolic disorders; however, whether the effects of uric acid on atherosclerosis are different in females and males has not... Aims: Serum uric acid increases with metabolic disorders; however, whether the effects of uric acid on atherosclerosis are different in females and males has... |
| SourceID | pubmedcentral proquest crossref pubmed medicalonline jstage |
| SourceType | Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 1672 |
| SubjectTerms | Atherosclerosis Carotid plaque Female Original Sex difference Uric acid |
| Title | Increased Impact of Serum Uric Acid on Arterial Stiffness and Atherosclerosis in Females |
| URI | https://www.jstage.jst.go.jp/article/jat/29/11/29_63368/_article/-char/en http://mol.medicalonline.jp/library/journal/download?GoodsID=ex7domya/2022/002911/013&name=1672-1691e https://www.ncbi.nlm.nih.gov/pubmed/35110425 https://search.proquest.com/docview/2625260544 https://pubmed.ncbi.nlm.nih.gov/PMC9623079 |
| Volume | 29 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Journal of Atherosclerosis and Thrombosis, 2022/11/01, Vol.29(11), pp.1672-1691 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEB9uDxFBxG_rxxHF1-5um7Rp31wO11NYEXRh30KSplwP2x7XLpz_vTNpu7jiky996TS0nY_8fpnJBOB9ohPtisiG2qYpLd3o0GQ8CssE0YkwUWR8s-fN1_RiK77skt0JJNNeGF-0b001b37W86a69LWV17VdTHVii2-b8zyl8uV8MYMZGuhE0Yfwy3EC9SlOLjDACJkN7YQSRAaLK93PU85TOqSPEmhksEfz0Z0rhGS01_5-PaRJhnYV_0KffxdR_jErrR_CgxFOstXw2o_gxDWP4e5mTJg_gR36P5Wdu4J99vshWVsyjA_7mm0xArKVrQrWNjSAN0X2va_KksIf003BVgQP2w6HxmvVsapha1fjnNI9he3644_zi3A8TCG0CDr6kCcOkeDSIV5w1lgjpUbqIS0vMmQ1LnJSL2NrEmMK5Kw2jmUpshzJm4tKJxGEPIPTpm3cC2CRtSLTOUekqUUZO720ObeF4NJwJNRxAO-mX6quh54ZCrkGqUChCpRXQQD58LMPIqOGvUicIzWhq5c93KKdaOjOAXw40o8a_a5T7lYWbf1LqxixiaKUIw6DKFdFqYwVNQYSSzowUwTwdlKpQoeiLIluXLvvVIyMkEieQJnng4oPrzgZTQDySPkHAWrWfXwHbdg37R5t9uV_P_kK7tFHDcs_r-G0v9m7NwiIenMGs0-76My7wW9XFAss |
| link.rule.ids | 230,315,730,783,787,888,27936,27937,53804,53806 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELaWBQESQjwWCE-DuKZNYidOblQrqi5sV0hspd4s23FEViRZkVSCf8-MnVQUceKSS6ZWmnn4-zIPE_I-VamyZWxCZbIMP92oUOcsDqsU0AnXcazdsOf1Rbba8E_bdHtE0qkXxhXtG13P2u_NrK2_udrK68bMpzqx-Zf1aZFh-XIxv0Fugr9GfCLpPgAz2EJdkpNxCDFc5H6gUArYYH6lhlnGWIbH9GEKDU32YEe6dQWgDLvt7zU-UeIHVvwLf_5dRvnHvrR8QO6PgJIu_IM_JEe2fURur8eU-WOyhQiAhee2pGeuI5J2FYUIsWvoBmIgXZi6pF2LCzhjpF-HuqowAFLVlnSBALHrYWm41j2tW7q0Dewq_QnZLD9enq7C8TiF0ADsGEKWWsCCkQXEYI02WggF5EMYVubAa2xshYoSo1OtS2CtJklExfMC6JuNKysAhjwhx23X2meExsbwXBUMsKbiVWJVZApmSs6EZkCpk4C8m16pvPZTMySwDVSBBBVIp4KAFP5l70VGHTuRpAByglcnu7-FvWjg0AH5cKAfOXpeL-1PUXbNLyUTQCcSk46wDOBcGWcikTgaiEd4ZCYPyNtJpRJcCvMkqrXdrpcJcEKkeRxknnoV7x9xMpqAiAPl7wVwXPfhHbBiN7Z7tNrn__3LN-TO6nJ9Ls_PLj6_IHfxD_quyJfkePixs68AHg36tXOG3z5uDZI |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagoAoJVbwKoQUM4prNw06c3Fi1rFpgq0qw0t4s23FEKpKsSFaCf8-Mk6y6iBOXXDKxEs_D35cZjwl5n6hE2SIyvjJpir9ulK8zFvllAuiE6yjSrtnz8iq9WPFP62R966gvV7RvdDVrftSzpvruais3tQmmOrHgenmWp1i-nAebogzuknvgs2E6EfUhCDNYRl2ik3EIM1xkQ1OhBPBBcKP6WcpYikf1YRoNzXZvVbp_A8AMd9w_rIdkydC04l8Y9O9Syltr0-IRORpBJZ0PL_-Y3LHNE3K4HNPmT8kaogAWn9uCXrpdkbQtKUSJbU1XEAfp3FQFbRscwBkk_dpXZYlBkKqmoHMEiW0HQ8O16mjV0IWtYWXpnpHV4uO3swt_PFLBNwA9ep8lFvBgaAE1WKONFkIBARGGFRlwGxtZocLY6ETrApiriWNR8iwHCmej0gqAIsfkoGkb-4LQyBieqZwB3lS8jK0KTc5MwZnQDGh17JF305TKzdA5QwLjQBVIUIF0KvBIPkz2TmTUsxOJcyAoeHWyu1u4Hw2c2iMf9vQjR-_rpP0lirb-rWQMCEVi4hGGAawro1TEEtsD8RCPzeQeeTupVIJbYa5ENbbddjIGXohUj4PM80HFu1ecjMYjYk_5OwFs2b1_ByzZte4eLfflfz_5hhxeny_kl8urzyfkAX7fsDHylBz0P7f2FSCkXr92vvAHHTsOpQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+Impact+of+Serum+Uric+Acid+on+Arterial+Stiffness+and+Atherosclerosis+in+Females&rft.jtitle=Journal+of+atherosclerosis+and+thrombosis&rft.au=Sugiura%2C+Tomonori&rft.au=Dohi%2C+Yasuaki&rft.au=Takagi%2C+Yasuyuki&rft.au=Yokochi%2C+Takashi&rft.date=2022-11-01&rft.pub=Japan+Atherosclerosis+Society&rft.issn=1340-3478&rft.eissn=1880-3873&rft.volume=29&rft.issue=11&rft.spage=1672&rft.epage=1691&rft_id=info:doi/10.5551%2Fjat.63368&rft_id=info%3Apmid%2F35110425&rft.externalDBID=PMC9623079 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1340-3478&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1340-3478&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1340-3478&client=summon |